GSK, Vertex Offer Refunds to 340B Providers
Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]
*Sign up for news summaries and alerts from 340B Report